Early Access — free while we kick the tires
EdgarHawk

Kurt J Hilzinger

Director

Director

Latest: Director buying · May 2026

1 filing analyzed · 1 company · Latest 2026-05-27

Never miss a filing from Kurt J Hilzinger

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Outlook Therapeutics, Inc. OTLK 1 0 Net buying

Activity

May 2026
high
Buy
400,000 shares
$176,520
Significance 7/10

Director Kurt J Hilzinger purchases 400,000 shares of OTLK at $0.44, raising stake 1691.0% to 423.7K shares

Director Kurt J Hilzinger acquired 400,000 shares at $0.44 on 2026-05-26, a massive 1691.0% increase in his position from 23.7K to 423.7K shares. The company is deeply unprofitable (net income of $-4.5M against quarterly revenue of $1.5M) and trading 84.7% below its 52-week high, yet the stock has gained 82.5% over the past 30 days. This substantial insider accumulation at a heavily depressed valuation—combined with the director's dramatic concentration of equity—occurs within a distressed fundamental context and following steep recent price recovery.

Related insiders